Scientists reprogram Patients' own cells to hunt deadly cancer mutations
NCT ID NCT06478251
First seen Jan 04, 2026 · Last updated Apr 05, 2026 · Updated 13 times
Summary
This early-stage study is testing a new type of personalized cell therapy for people with advanced solid tumors that have specific KRAS gene mutations. Doctors will collect a patient's own immune cells, genetically modify them in a lab to recognize and attack cancer cells with KRAS mutations, and then infuse them back into the patient. The main goals are to see if this treatment is safe and to find the right dose, while also checking for any early signs that it might shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUMOR, SOLID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Zhejiang University school of Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.